Kidney Care UK and pharmacists sound the alarm on ibuprofen and kidney health
A Kidney Care UK survey has found that three quarters of people living with kidney disease were not aware that certain over-the-counter pain medications like ibuprofen can affect the kidneys. Working with the National Pharmacy Association, we are urging patients to be aware of the risks of NSAIDS (non-steroidal anti-inflammatory drugs).
Read the storyFilters
-
New treatment for IgA nephropathy (IgAN) in Scotland
Adults living in Scotland who have IgA nephropathy (IgAN) will now, in certain circumstances, be able to access a new treatment on the NHS following a decision made today by the Scottish Medicines Consortium (SMC).
-
Kidney Care UK and Kidney Wales unite for awareness campaign
Kidney Care UK and Kidney Wales have joined forces to roll out a nationwide awareness campaign to reach people at risk of developing chronic kidney disease (CKD) in Wales. This is the first widespread pan-Wales kidney disease awareness campaign of its kind.
-
Tribute to Professor Paula Ormandy
A tribute to kidney nursing, research and patient involvement leader Professor Paula Ormandy. Paula’s contribution to renal nursing, research and the development of future kidney healthcare leaders leaves a remarkable legacy that will continue to shape kidney care in the UK for years to come.
-
New study suggests changing blood tests could improve early stage kidney disease diagnosis
A blood test is one of the main ways to get tested for chronic kidney disease (CKD). A recently published story has suggested that changing the blood tests doctors use to calculate a person’s kidney function could improve kidney disease diagnosis and monitoring,
-
First treatment for IgA nephropathy approved for use in Scotland
Following their recent assessment, to which Kidney Care UK made a patient group submission, the Scottish Medicines Consortium (SMC) has accepted the medicine budesonide (Kinpeygo®) for use by NHS Scotland for treating adults with IgA nephropathy (IgAN), a rare kidney condition.
-
Kidney Care UK welcomes guidance extending access to medication for high potassium levels
Kidney Care UK welcomes new guidance from the National Institute for Health and Care Excellent (NICE) that extends access to a treatment for hyperkalaemia (high potassium levels), a common condition in people with kidney problems.
-
New centres specialising in organ perfusion technology could cut through longest kidney transplant waiting list ever
The first of 15 specialised centres across the UK has been opened by NHS Blood and Transplant (NHSBT) as part of a pilot scheme to increase the use of organ perfusion technology and enable hundreds of additional kidney transplants a year, at a time when the transplant waiting list is longer than ever.
-
Kidney Care UK at UK Kidney Week 2026
Kidney Care UK was proud to promote our work to improve quality of life for everyone with kidney disease at this year's UK Kidney Week in Harrogate. Organised every year by the UK Kidney Association (UKKA), the event brings healthcare professionals, researchers and organisations working on kidney health together in one place.
-
Advice for people with kidney disease regarding the meningitis outbreak in Kent
There is an ongoing meningococcal disease outbreak in Kent. Some cases in this outbreak are now confirmed to be meningitis B, known as MenB. The outbreak is attracting a large amount of media attention, and Kidney Care UK understands some people with kidney disease will be feeling worried.
-
Disappointment at NICE draft decision not to recommend a new drug for rare kidney condition
Pegcetacoplan (Aspaveli), a new medicine for people with rare kidney conditions C3 glomerulopathy (C3G) and immune complex membranoproliferative glomerulonephritis (IC-MPGN), is not recommended as an NHS funded treatment following a NICE (National Institute for Health and Care Excellence) draft recommendation published Friday 13 March.
-
Kidney Care UK and pharmacists sound the alarm on ibuprofen and kidney health
A Kidney Care UK survey has found that three quarters of people living with kidney disease were not aware that certain over-the-counter pain medications like ibuprofen can affect the kidneys. Working with the National Pharmacy Association, we are urging patients to be aware of the risks of NSAIDS (non-steroidal anti-inflammatory drugs).
-
Celebrating our #KidneyWarriors this World Kidney Day
With 150 runners, expected to raise a combined £450,000, Kidney Care UK's team for the TCS London Marathon 2026 is our biggest yet. Around one third of the team are people living with kidney disease or healthcare professionals working with kidney patients, as well as a number of living kidney donors.
-
Get involved with World Kidney Day 2026
We're celebrating 20 years of World Kidney Day, the worldwide campaign to raise awareness of chronic kidney disease (CKD) and help people to understand how important kidneys are to our health. Find out how you can get involved in World Kidney Day 2026.
-
Celebrate 20 years of World Kidney Day
12 March 2026 will mark 20 years of World Kidney Day, the worldwide campaign dedicated to raising global awareness of the importance of kidneys to our health and combatting chronic kidney disease (CKD).
-
NICE recommends two medicines to treat conditions causing kidney disease
Kidney Care UK are pleased to share that the National Institute for Health and Care Excellence (NICE) have recommended two medicines for use in lupus nephritis and IgA nephropathy (IgAN), which both cause kidney disease.
-
Five reasons to be optimistic about kidney care in 2026
There are plenty of reasons to be optimistic about the state of kidney care in 2026, from global and UK organisations making kidneys a priority to Kidney Care UK's nation-wide campaigns.
-
New report calls for systemic changes to stop kidney disease diagnosis through NHS app, without proper support and guidance
The Falling through the GApp report highlights that systemic changes are needed to ensure thousands of people do not find out they have chronic kidney disease (CKD) via the NHS App, without the support and context needed to come to terms with the diagnosis.
-
New treatment for nephropathic cystinosis approved for use in NHS Scotland
A new treatment option for cystinosis, a rare inherited condition initially severely affecting the kidney and eyes usually diagnosed in infants, will soon be available to patients in Scotland, providing a less disruptive alternative to current treatments – and leaving England the only nation in the UK with more limited treatment options.
-
Rare kidney diseases are ‘collectively common’ and severely disrupt children’s lives, new report reveals
A new report from Kidney Research UK has found that kidney diseases classed as 'rare' collectively affect over 100,00 people in the UK, and are having a devastating impact on patients' lives – particularly those of children.
-
Stay warm and well this winter
As we head into the winter months, we are working with the NHS to make sure everyone living with chronic kidney disease (CKD) knows how to keep warm and well in the colder weather and get the support they need.
-
Our #BloodyAmazingKidneys campaign is coming to a street near you!
Kidney Care UK has been selected as the JCDecaux Community Channel Partner for October 2025. This means that, throughout the month, our #BloodyAmazingKidneys campaign will be seen on billboards across the UK, helping thousands more people find out about Kidney Care UK and the importance of kidney health.